Dr. Gerhard Racz has over 21 years of experience specializing in General Medicine, Gastroenterology, and Hepatology. He is currently serving as a Senior Consultant at Oberwart General Hospital, where he focuses on the diagnosis and treatment of gastrointestinal and liver diseases. Dr. Racz's career began at the Medical University of Vienna, where he completed his residency before joining Oberwart General Hospital. Over the years, he has built a reputation for his expertise in treating complex liver diseases, including cirrhosis, hepatitis, and liver cancer. His work in gastroenterology and hepatology has helped shape current clinical practices in the management of gastrointestinal conditions in Austria.
rnMedical University of Vienna (MedUni Vienna)rn · Doctor of Medicine (MD) · Year: 2004
Dr. Racz has been actively involved in research, particularly in the field of liver diseases and gastrointestinal health. His work has focused on advancing early diagnostic techniques for liver cancer and improving treatment strategies for chronic liver diseases. He has contributed to several landmark studies on hepatitis C treatments and liver transplantation outcomes. Dr. Racz's research has been published in numerous respected medical journals, and he has presented his findings at international medical conferences. His innovative research has influenced clinical practices and treatment protocols, especially in hepatology.
Best Gastroenterologist of the Year – Oberwart General Hospital, 2020
Outstanding Contribution to Liver Disease Research – Medical University of Vienna, 2018
Excellence in Clinical Care Award – Oberwart General Hospital, 2019
Dr. Gerhard Racz has authored multiple influential papers in the field of gastroenterology and hepatology. His notable publication on innovative therapies in liver disease was featured in the Journal of Hepatology, and his research on liver transplantation outcomes was published in The European Journal of Gastroenterology. Additionally, Dr. Racz has co-authored studies on liver fibrosis progression and hepatitis C management, contributing to the current global understanding of these diseases. His work continues to be highly regarded in the medical community and has shaped the modern approach to managing chronic liver diseases.
Consultation fees are indicative and subject to change.
Consultation fees are indicative and subject to change.
The information on MyHospitalNow is for general informational purposes only and does not constitute medical advice. Consultation fees shown are indicative and subject to change. Always consult a qualified healthcare professional for diagnosis and treatment.